These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24289842)

  • 1. Multiple sclerosis spasticity epidemiology--key publications.
    Gold R
    Expert Rev Neurother; 2013 Dec; 13(12 Suppl):45-6. PubMed ID: 24289842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is new in MS spasticity research? Poster session highlights.
    Kappos L; Fazekas F
    Neurodegener Dis Manag; 2015; 5(6 Suppl):27-30. PubMed ID: 26611269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis spasticity management--key publications.
    Gold R
    Expert Rev Neurother; 2013 Dec; 13(12 Suppl):47-8. PubMed ID: 24289843
    [No Abstract]   [Full Text] [Related]  

  • 4. Country break-out session highlights.
    Fazekas F; Gehring K; Gallo P; Lebrun-Frénay C; Moral E; Myhr KM
    Neurodegener Dis Manag; 2015; 5(6 Suppl):31-7. PubMed ID: 26611270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is new in multiple sclerosis spasticity research? Poster session highlights.
    Ghezzi A
    Neurodegener Dis Manag; 2016 Dec; 6(6s):45-47. PubMed ID: 27874498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiology and clinical assessment of spasticity in multiple sclerosis].
    Bensmail D; Vermersch P
    Rev Neurol (Paris); 2012 Apr; 168 Suppl 3():S45-50. PubMed ID: 22721364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spasticity in multiple sclerosis: results of a patient survey.
    Oreja-Guevara C; González-Segura D; Vila C
    Int J Neurosci; 2013 Jun; 123(6):400-8. PubMed ID: 23297730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spasticity in multiple sclerosis].
    Pappalardo A; Patti F; Reggio A; Guglielmino A; Mangiameli S
    Clin Ter; 2004 Apr; 155(4):135-8. PubMed ID: 15354762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing specific symptoms in people with multiple sclerosis.
    Henze T
    Int MS J; 2005 Aug; 12(2):60-8. PubMed ID: 16417816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Country breakout session highlights.
    Ghezzi A; Filli L; Solaro C; Mekies C; Landete L; Lycke J
    Neurodegener Dis Manag; 2016 Dec; 6(6s):41-44. PubMed ID: 27874497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Consensus document on spasticity in patients with multiple sclerosis. Grupo de Enfermedades Desmielinizantes de la Sociedad Española de Neurología].
    Oreja-Guevara C; Montalban X; de Andrés C; Casanova-Estruch B; Muñoz-García D; García I; Fernández Ó;
    Rev Neurol; 2013 Oct; 57(8):359-73. PubMed ID: 24081891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into multiple sclerosis and advances in multiple sclerosis spasticity management.
    Gold R
    Expert Rev Neurother; 2013 Dec; 13(12 Suppl):1-2. PubMed ID: 24289835
    [No Abstract]   [Full Text] [Related]  

  • 13. [Editorial. Spasticity in multiple sclerosis].
    Vermersch P
    Rev Neurol (Paris); 2012 Apr; 168 Suppl 3():S35. PubMed ID: 22721362
    [No Abstract]   [Full Text] [Related]  

  • 14. Overview of spasticity management in multiple sclerosis. Evidence-based management strategies for spasticity treatment in multiple sclerosis.
    Haselkorn JK; Balsdon Richer C; Fry Welch D; Herndon RM; Johnson B; Little JW; Miller JR; Rosenberg JH; Seidle ME;
    J Spinal Cord Med; 2005; 28(2):167-99. PubMed ID: 15889701
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple sclerosis and fracture.
    Ye S; Wu R; Wu J
    Int J Neurosci; 2013 Sep; 123(9):609-16. PubMed ID: 23510118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epilepsy and multiple sclerosis: Increased risk among progressive forms.
    Martínez-Juárez IE; López-Meza E; González-Aragón Mdel C; Ramírez-Bermúdez J; Corona T
    Epilepsy Res; 2009 Apr; 84(2-3):250-3. PubMed ID: 19329280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity guidelines.
    Gold R; Oreja-Guevara C
    Expert Rev Neurother; 2013 Dec; 13(12 Suppl):55-9. PubMed ID: 24289845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical case reviews in multiple sclerosis spasticity: experiences from around Europe.
    Koehler J; Amato MP; Oreja-Guevara C; Lycke J
    Expert Rev Neurother; 2013 Dec; 13(12 Suppl):61-6. PubMed ID: 24289846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the management of multiple sclerosis-related spasticity.
    Hartung HP
    Expert Rev Neurother; 2012 Apr; 12(4 Suppl):1. PubMed ID: 22509984
    [No Abstract]   [Full Text] [Related]  

  • 20. FES cycling reduces spastic muscle tone in a patient with multiple sclerosis.
    Krause P; Szecsi J; Straube A
    NeuroRehabilitation; 2007; 22(4):335-7. PubMed ID: 17971625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.